Insider: Kumar Neil Chief Executive Officer - BridgeBio Pharma, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 223,518 | 875,686 | 1,099,204 |
| Value | $10,952,382.00 | $42,908,614.00 | $53,860,996.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/05/2025 | DDS | 800 | Indirect | COM | $53.80 | $43,039.52 | 875,686 |
| 09/05/2025 | DDS | 2,300 | Indirect | COM | $51.95 | $119,495.58 | 4,696,147 |
| 09/05/2025 | DDS | 900 | Indirect | COM | $53.80 | $48,423.96 | 4,678,447 |
| 09/05/2025 | DDS | 16,800 | Indirect | COM | $53.16 | $893,124.96 | 4,679,347 |
| 09/05/2025 | DDS | 2,300 | Indirect | COM | $51.96 | $119,513.75 | 893,386 |
| 09/05/2025 | DDS | 16,900 | Indirect | COM | $53.16 | $898,449.63 | 876,486 |
| 09/04/2025 | DDS | 14,525 | Indirect | COM | $51.15 | $742,959.56 | 4,703,922 |
| 09/04/2025 | DDS | 5,475 | Indirect | COM | $51.85 | $283,902.29 | 4,698,447 |
| 09/04/2025 | DDS | 5,442 | Indirect | COM | $51.85 | $282,186.75 | 895,686 |
| 09/04/2025 | DDS | 14,558 | Indirect | COM | $51.16 | $744,739.24 | 901,128 |
| 08/20/2025 | DDS | 25,728 | Direct | COM | $48.81 | $1,255,848.00 | 223,518 |
| 08/20/2025 | DDS | 428 | Direct | COM | $49.25 | $21,079.17 | 223,090 |
| 08/08/2025 | DDS | 11,795 | Indirect | COM | $45.88 | $541,161.68 | 4,726,652 |
| 08/08/2025 | DDS | 8,205 | Indirect | COM | $46.71 | $383,252.27 | 4,718,447 |
| 08/08/2025 | DDS | 8,205 | Indirect | COM | $46.71 | $383,252.27 | 915,686 |
| 08/08/2025 | DDS | 11,795 | Indirect | COM | $45.88 | $541,161.68 | 923,891 |
| 08/07/2025 | DDS | 6,784 | Indirect | COM | $45.09 | $305,908.88 | 4,751,663 |
| 08/07/2025 | DDS | 13,216 | Indirect | COM | $45.64 | $603,151.81 | 4,738,447 |
| 08/07/2025 | DDS | 6,784 | Indirect | COM | $45.09 | $305,908.88 | 948,902 |
| 08/07/2025 | DDS | 13,216 | Indirect | COM | $45.64 | $603,151.81 | 935,686 |
| 07/02/2025 | DDS | 20,000 | Indirect | COM | $42.73 | $854,536.00 | 4,758,447 |
| 07/02/2025 | DDS | 20,000 | Indirect | COM | $42.73 | $854,514.00 | 955,686 |
| 07/01/2025 | DDS | 18,300 | Indirect | COM | $42.50 | $777,777.45 | 4,780,147 |
| 07/01/2025 | DDS | 1,700 | Indirect | COM | $42.88 | $72,902.97 | 4,778,447 |
| 07/01/2025 | DDS | 18,400 | Indirect | COM | $42.51 | $782,092.00 | 977,286 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research